HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Cysview safely and effectively. See full prescribing information for Cysview. Cysview (hexaminolevulinate hydrochlor

First Page		Document Content
Date: 2010-06-03 18:47:48 Cysview Endoscopy Bladder cancer Cystoscopy Urinary retention Urination Urinary catheterization Hematuria Bladder spasm Medicine Oncology Catheters		HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Cysview safely and effectively. See full prescribing information for Cysview. Cysview (hexaminolevulinate hydrochlor Add to Reading List Source URL: www.accessdata.fda.gov Download Document from Source Website File Size: 193,89 KB Share Document on Facebook

	Episodes of Care Section II TOC is required DocID: 1pSUN - View Document
	FOR PUBLICATION UNITED STATES COURT OF APPEALS FOR THE NINTH CIRCUIT ALLEN L. TREICHLER, DocID: 1pQd6 - View Document
	Incontinence EDUCATIONAL SUPPLEMENT and Parkinson’s Disease By Debbie Guyer, MA, CCC-SLP DocID: 1poFO - View Document
	URINARY RETENTION (ISS MED/3A - ALL/FIN) Page 1 of 4 pages NOTE DocID: 1nXGs - View Document
	Pediatric Urology – Patient Education Handout Voiding Dysfunction Eric A. Kurzrock, M.D. Paula J. Wagner, RN, FNP DocID: 1nWvI - View Document